These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 21093891

  • 1. Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.
    Eroğlu A, Akar N.
    Thromb Res; 2011 Apr; 127(4):384-5. PubMed ID: 21093891
    [No Abstract] [Full Text] [Related]

  • 2. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A, Egin Y, Cam R, Akar N.
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [Abstract] [Full Text] [Related]

  • 3. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [Abstract] [Full Text] [Related]

  • 4. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [Abstract] [Full Text] [Related]

  • 5. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.
    Hepatogastroenterology; 2007 Jun; 54(77):1438-42. PubMed ID: 17708272
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS, Rihani G.
    Clin Lab Sci; 2004 Jun; 17(4):200-2. PubMed ID: 15559724
    [Abstract] [Full Text] [Related]

  • 7. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [Abstract] [Full Text] [Related]

  • 8. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.
    J Natl Cancer Inst; 2006 Jul 05; 98(13):904-10. PubMed ID: 16818854
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B, Boroujeni HR, Hasheminia AM, Drees F.
    Blood Coagul Fibrinolysis; 2013 Jul 05; 24(5):471-6. PubMed ID: 23358226
    [Abstract] [Full Text] [Related]

  • 11. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.
    Blood Coagul Fibrinolysis; 2009 Dec 05; 20(8):675-8. PubMed ID: 19710606
    [Abstract] [Full Text] [Related]

  • 12. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J.
    Blood Coagul Fibrinolysis; 2006 Jan 05; 17(1):23-8. PubMed ID: 16607075
    [Abstract] [Full Text] [Related]

  • 13. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ, Becker RC.
    Am Heart J; 2003 Dec 05; 146(6):948-57. PubMed ID: 14660985
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.
    Hussein AS.
    J Thromb Thrombolysis; 2012 Oct 05; 34(3):383-7. PubMed ID: 22528331
    [Abstract] [Full Text] [Related]

  • 15. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C.
    Clin Ter; 2003 Oct 05; 154(5):299-303. PubMed ID: 14994919
    [Abstract] [Full Text] [Related]

  • 16. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.
    Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J.
    Transplantation; 2007 Apr 27; 83(8):1055-8. PubMed ID: 17452895
    [Abstract] [Full Text] [Related]

  • 17. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
    Koksal V, Baris I, Etlik O.
    Exp Mol Pathol; 2007 Aug 27; 83(1):1-3. PubMed ID: 17275807
    [Abstract] [Full Text] [Related]

  • 18. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB, Elhan AH, Tükün A, Toydemir R, Gürler A, Tüzüner A, Bökesoy I.
    J Rheumatol; 2000 Dec 27; 27(12):2849-54. PubMed ID: 11128675
    [Abstract] [Full Text] [Related]

  • 19. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S, Keskin N, Keskin A, Atalay E.
    Clin Appl Thromb Hemost; 2007 Apr 27; 13(2):166-71. PubMed ID: 17456626
    [Abstract] [Full Text] [Related]

  • 20. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
    Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY.
    Am J Hematol; 2004 Jul 27; 76(3):307-9. PubMed ID: 15224376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.